Literature DB >> 30615863

Natural modulators of the hallmarks of immunogenic cell death.

Flavia Radogna1, Mario Dicato1, Marc Diederich2.   

Abstract

Natural compounds act as immunoadjuvants as their therapeutic effects trigger cancer stress response and release of damage-associated molecular patterns (DAMPs). These reactions occur through an increase in the immunogenicity of cancer cells that undergo stress followed by immunogenic cell death (ICD). These processes result in a chemotherapeutic response with a potent immune-mediating reaction. Natural compounds that induce ICD may function as an interesting approach in converting cancer into its own vaccine. However, multiple parameters determine whether a compound can act as an ICD inducer, including the nature of the inducer, the premortem stress pathways, the cell death pathways, the intrinsic antigenicity of the cell, and the potency and availability of an immune cell response. Thus, the identification of hallmarks of ICD is important in determining the prognostic biomarkers for new therapeutic approaches and combination treatments.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Cancer immunotherapy; Danger-associated molecular patterns; ER stress; Immunogenic cell death; Necroptosis

Year:  2019        PMID: 30615863     DOI: 10.1016/j.bcp.2018.12.016

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

Review 1.  Emerging role of natural products in cancer immunotherapy.

Authors:  Songtao Dong; Xiangnan Guo; Fei Han; Zhonggui He; Yongjun Wang
Journal:  Acta Pharm Sin B       Date:  2021-08-21       Impact factor: 14.903

2.  Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours.

Authors:  Daniel D Karp; D Ross Camidge; Jeffery R Infante; Tyler D Ames; Matthew R Price; José Jimeno; Alan H Bryce
Journal:  EClinicalMedicine       Date:  2022-05-27

3.  Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia.

Authors:  Sungmi Song; Jin-Young Lee; Ludmila Ermolenko; Aloran Mazumder; Seungwon Ji; Heeju Ryu; HyeJin Kim; Dong-Wook Kim; Jung Weon Lee; Mario Dicato; Christo Christov; Michael Schnekenburger; Claudia Cerella; Déborah Gérard; Barbora Orlikova-Boyer; Ali Al-Mourabit; Marc Diederich
Journal:  Cell Death Dis       Date:  2020-02-07       Impact factor: 8.469

Review 4.  Natural products in drug discovery: advances and opportunities.

Authors:  Atanas G Atanasov; Sergey B Zotchev; Verena M Dirsch; Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2021-01-28       Impact factor: 112.288

Review 5.  Role of Damage-Associated Molecular Pattern/Cell Death Pathways in Vaccine-Induced Immunity.

Authors:  Sun Min Lee; Paul Kim; Jinsuh You; Eui Ho Kim
Journal:  Viruses       Date:  2021-11-23       Impact factor: 5.048

6.  The role of reactive oxygen species in the immunity induced by nano-pulse stimulation.

Authors:  Siqi Guo; Niculina I Burcus; Megan Scott; Yu Jing; Iurii Semenov
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

7.  Schweinfurthin induces ICD without ER stress and caspase activation.

Authors:  Ruoheng Zhang; J D Neighbors; T D Schell; R J Hohl
Journal:  Oncoimmunology       Date:  2022-08-03       Impact factor: 7.723

Review 8.  An Overview on Immunogenic Cell Death in Cancer Biology and Therapy.

Authors:  Mosar Corrêa Rodrigues; José Athayde Vasconcelos Morais; Rayane Ganassin; Giulia Rosa Tavares Oliveira; Fabiana Chagas Costa; Amanda Alencar Cabral Morais; Ariane Pandolfo Silveira; Victor Carlos Mello Silva; João Paulo Figueiró Longo; Luis Alexandre Muehlmann
Journal:  Pharmaceutics       Date:  2022-07-27       Impact factor: 6.525

9.  Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones.

Authors:  Fangtian Fan; Peiliang Shen; Yue Ma; Wangbo Ma; Hongyan Wu; Hao Liu; Qing An
Journal:  J Inflamm (Lond)       Date:  2021-06-10       Impact factor: 4.981

10.  Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death.

Authors:  Joanna Kopecka; Martina Godel; Silvia Dei; Roberta Giampietro; Dimas Carolina Belisario; Muhlis Akman; Marialessandra Contino; Elisabetta Teodori; Chiara Riganti
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.